Panel Discussion: Navigating India Pharma Inc’s challenges and opportunities

Panelists in this video:
+ Dr Rakesh Bhasin, Head R&D (Formulations), Biocon (Moderator)
+ Mr Elayaraja Natarajan, VP- R&D, Lyrus Life Sciences
+ Mr Mayank Garg, Head:MSAT – mAbs, Biocon Biologics
+ Mr Chandrashekar Rao, VP-Corporate Quality, Althera Laboratories
+ Mr Manjunath Nadella, AVP & Head -Packaging Development, Strides Pharma Science

Key Highlights:
[1] Technology transfer is a complex procedure that faces challenges of scale, consistency, process complexities and regulatory scrutiny

[2] Technologies like digitisation, automation, data analytics and AI/ML are enhancing pharma/biopharma processes such as manufacturing, operations, R&D and regulatory filing

[3] Packaging in pharma is getting transformed through the use of novel materials, emerging technologies, innovative design, evolving customer demands and the need for sustainability

[4] The supply chain has become an extremely crucial function. Ensuring end-to-traceability and visibility to ensure the safety and efficacy of pharma products is pivotal

[5] As the pharma sector advances, it should also become more responsible and eco-conscious. Therefore, sustainability and ESG are important areas that need strategic measures and investments